Wednesday, February 15, 2006


Viral Hepatitis C - Jay Farrar rebuilds a no-frills Son Volt


Jay Farrar rebuilds a no-frills Son Volt
Fort Wayne News-Sentinel - Feb 15 2:13 PM
If you've seen Jay Farrar onstage - be it with alt-country favorite Uncle Tupelo, with the early version of Son Volt, or on his own - you know this is an artist not exactly prone to outbursts of laughter.Save to My Web

Nabi Biopharmaceuticals Announces U.S. Fast Track Designation for Civacir to Prevent Hepatitis C Re-Infection in Liver
RedNova - Feb 01 9:15 PM
ROCKVILLE, Md., Feb. 1 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals today announced important regulatory and clinical advancements for its product candidate Civacir(TM) [Hepatitis C Immune Globulin (Human)], an antibody for preventing Hepatitis C virus re-infection in liver transplants.Save to My Web

Most common hepatitis C virus grown in lab
Galveston County Daily News - Feb 06 10:22 PM
GALVESTON Researchers at the University of Texas Medical Branch at Galveston have successfully grown the most common and damaging form of the hepatitis C virus in human liver cell cultures.Save to My Web

GSK Announces Start Of Eltrombopag Phase III Worldwide Clinical Trial In Adults With Previously-Treated Idiopathic
Medical News Today - Feb 14 1:02 PM
GlaxoSmithKline plc (GSK) announced today the commencement of a worldwide clinical trial to investigate the safety and efficacy of eltrombopag (SB-497115-GR) as a once-daily orally-administered drug for adult patients with previously-treated idiopathic thrombocytopenic purpura (ITP). ITP is a disorder characterized by low platelet counts leaving patients at risk of episodes of spontaneous Save to My Web